LISA BRIGHTWELL: Open Payments
NPI 1316421597 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 94 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $461 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $362 |
| ABBVIE INC. | 14 | $358 |
| Amgen Inc. | 18 | $303 |
| Janssen Biotech, Inc. | 9 | $198 |
| Novartis Pharmaceuticals Corporation | 8 | $157 |
| Fresenius Kabi USA, LLC | 4 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| SOBI, INC | 3 | $81 |
| Organon LLC | 2 | $52 |
| Lilly USA, LLC | 2 | $40 |
Products named: Bimzelx, RINVOQ, TREMFYA, SKYRIZI, COSENTYX, EVENITY, SAPHNELO, Kineret.
Industry payments across SC — which companies pay providers there.
